Last reviewed · How we verify
Boric Acid Vaginal Suppository — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Boric Acid Vaginal Suppository (Boric Acid Vaginal Suppository) — Hatem AbuHashim. Creates an acidic vaginal environment that inhibits growth of pathogenic fungi and bacteria while supporting normal vaginal flora.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Boric Acid Vaginal Suppository TARGET | Boric Acid Vaginal Suppository | Hatem AbuHashim | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Boric Acid Vaginal Suppository CI watch — RSS
- Boric Acid Vaginal Suppository CI watch — Atom
- Boric Acid Vaginal Suppository CI watch — JSON
- Boric Acid Vaginal Suppository alone — RSS
Cite this brief
Drug Landscape (2026). Boric Acid Vaginal Suppository — Competitive Intelligence Brief. https://druglandscape.com/ci/boric-acid-vaginal-suppository. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing